نتائج البحث - M. Manzanares

OP 5.3 - 00082 1-year treatment with ponatinib provides protection of CD4+T cells against HIV that is maintained at least 1 year more after treatment interruption حسب M. Manzanares, F. Ramos-Martín, G. Casado-Fernández, M. Torres, E. Mateos, L. Vigón, S. Rodríguez-Mora, V. García-Gutiérrez, V. Planelles, M. Coiras

Connect to this object online.